Anti-hemojuvelin (HJV) antibodies for treating myelofibrosis
AssigneesDisc Medicine, Inc., AbbVie Inc., AbbVie Deutschland GmbH & Co. KG
InventorsMaria Beconi, John Quisel, Brian MacDonald, Steven Robinette, Bernhard Mueller, Andreas Popp, Jennifer M. Perez
Life of this patent
Estimating the term…
Abstract
Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating myelofibrosis and/or conditions associated with myelofibrosis.
Claims22
An isolated antibody that binds to human hemojuvelin (HJV), wherein the isolated antibody comprises a heavy chain variable region (VH) comprising the amino acid sequence of SEQ ID NO:
- 38, and a light chain variable region (VL) comprising the amino acid sequence of SEQ ID NO:
- 39.
A composition comprising anti-human hemojuvelin (HJV) antibodies comprising a heavy chain variable region (VH) comprising the amino acid sequence of SEQ ID NO:
- 38, and a light chain variable region (VL) comprising the amino acid sequence of SEQ ID NO:
- 39.
Dependencies are inferred from the claim text.